Unitree Robotics' blockbuster first trading day in Shanghai - a greater than seven-fold jump taking its valuation above $50 billion - has put the spotlight back on China’s robotics industry. The enthusiasm around Unitree’s IPO focused investor attention on the humanoid-robotation narrative, but it also coincided with a notable pullback in other listed robotics names.
Markets digested the debut with a bout of selling in the group. UBTECH Robotics slid 10.4% and Estun Automation tumbled 13%, while the Global X China Robotics & AI ETF fell 4.9% during the same session. The moves underline how quickly sentiment can swing when one public offering reanchors expectations about the sector’s near-term prospects.
At the heart of the issue is a familiar structural challenge: the sector is heavily growth-oriented but light on profits. According to the data referenced here, five of China’s six major listed robotics companies are loss-making even as revenue expands impressively - with topline growth rates in the range of 17% to 58% across the group.
That leaves investors looking for tradable, durable profit streams. Among the six names, only Shenzhen Inovance Technology currently reports positive earnings and a conservative balance sheet, making it the outlier in an otherwise loss-making cohort.
Shenzhen Inovance Technology stands out as the industrial core of the segment, supplying servo motors, PLCs and factory automation systems that underpin robotics manufacturing. The company is priced at CNY 59.91 and shows the following metrics: trailing P/E 35.5x, forward P/E 28.8x, return on equity 14.4%, debt-to-equity 8.5% and a calculated fair-value upside of +25.4%. Revenue grew 17.1% and the company carries a low debt load - a combination the data suggest makes it the closest thing to a picks-and-shovels exposure in Chinese robotics.
By contrast, the rest of the publicly traded names in the sector exhibit substantially weaker profitability or elevated leverage even where revenue growth is strong. The table below presents the data points supplied for several key companies.
| Company | Price | P/E LTM | Rev Growth | ROE | D/E | Fair Value |
|---|---|---|---|---|---|---|
| UBTECH Robotics | HKD 84.95 | -58.3x | 53.3% | -15.1% | 16.2% | -18.4% |
| Horizon Robotics (9660) | HKD 4.76 | -5.7x | 57.7% | -85.3% | 123.1% | +11.6% |
| SenseTime (0020) | HKD 1.44 | -29.6x | 32.9% | -7.0% | 22.3% | -11.1% |
| Estun Automation | CNY 36.04 | 281.1x | 14.4% | 5.1% | 116.1% | -28.2% |
| SIASUN Robot (300024) | CNY 15.51 | -59.3x | -0.7% | -10.4% | 58.8% | -31.6% |
All figures as of Aug 19, 2026.
UBTECH is the most direct public analogue to Unitree in terms of product mix - humanoid and service robots among other offerings. Despite revenue nearly doubling, the company posts a negative forward P/E, reflecting analyst expectations that earnings are still distant. The session decline of 10.4% is consistent with a cooling of speculative momentum following Unitree’s headline-grabbing listing.
Horizon Robotics (ticker 9660) presents a different profile - very high revenue growth of 57.7% tied to its AI chip and autonomous driving processor business, but a deeply negative ROE and a debt-to-equity ratio of 123.1% that point to heavy leverage and cash burn. Horizon is one of only two names in the table showing a positive fair-value gap, at +11.6%.
Other listed firms such as UBTECH, SenseTime (0020) and SIASUN (300024) are characterized here as speculative public-market versions of venture-style bets: top-line growth is often meaningful, but profitability is negative and fair-value metrics are below current prices. The day’s declines among these names reflect that volatility.
The wider conclusion from the price action and underlying metrics is that opportunities in China’s listed robotics universe are selective. Shenzhen Inovance appears as the quality choice on earnings and balance-sheet metrics. Horizon may offer growth but carries financing risk. The remaining names are loss-making and have fair-value assessments that do not currently support their market prices.
Finally, the Unitree IPO may have represented a high-water mark for investor enthusiasm in the near term. For most listed peers, the public-market proposition remains that of early-stage, venture-like ventures rather than established industrial compounders - with Inovance the notable exception.
Key takeaways
- Unitree surged more than sevenfold on its Shanghai debut, valuing the company at over $50 billion and refocusing attention on robotics equities.
- Five of six major listed Chinese robotics firms are loss-making despite revenue growth ranging roughly 17% to 58%.
- Shenzhen Inovance Technology is the only consistently profitable name with a conservative balance sheet and a positive fair-value gap.
Risks and uncertainties
- Sentiment risk - IPO-driven enthusiasm can reverse quickly, as seen in the post-Unitree selling that pushed several stocks sharply lower; this affects equity investors in robotics and related industrial automation firms.
- Profitability and leverage - most listed names are loss-making or highly leveraged, which raises financing and execution risk for shareholders in robot makers and AI chip suppliers.
- Valuation gaps - several companies trade at prices not supported by current fair-value calculations, exposing investors in robotics and AI ETFs to potential downside if earnings fail to materialize.